SV

Suryaprakasam Vedam Lakshmi Ramprasad

Active Director Ceo DIN 09618800
DIN 09618800 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since May 2022
Shareholding value •••• Premium profile

About Suryaprakasam Vedam Lakshmi Ramprasad

Data last updated:

Suryaprakasam Vedam Lakshmi Ramprasad is a Ceo at Medgenome Labs Limited (since 2023), Director at Genx Diagnostics Limited (since 2024) and Director at Trident Diagnostics & Healthcare Private Limited (since 2022), and holds 4 more current directorships. The companies operate in Healthcare. The 7 current companies with reported revenue have a combined latest revenue of ₹509 Cr; the largest is Medgenome Labs Limited at ₹407 Cr (FY 2025).

DIN 09618800
Primary Designation Ceo
Industry Healthcare
First Appointment 20 May 2022
Oldest Company Age 13 yrs
Largest company Medgenome Labs Limited · ₹407 Cr (FY 2025)
Combined revenue ₹509 Cr across 7 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medgenome Labs Limited U73100KA2013PLC084414
Ceo16 Nov 20232013₹407 Cr (FY 2025)Active
Genx Diagnostics Limited U85195OR2016PLC019956
Director21 Aug 20242016₹36.97 Cr (FY 2025)Active
Director20 May 20222016₹27.99 Cr (FY 2025)Active
Prl Diagnostics Private Limited U86905DL2023PTC410679
Director10 Apr 20242023₹20.75 Cr (FY 2025)Active
Additional Director18 Nov 20252014₹13.25 Cr (FY 2022)Active
Immucare Diagnostics Private Limited U85300KL2019PTC057597
Director26 Mar 20242019₹2.37 Cr (FY 2025)Active
Ans Diagnostics Private Limited U86905KA2023PTC171964
Director10 Apr 20242023₹95.2 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Trident Diagnostics & Healthcare Private Limited
Green Cross Genetics Lab Private Limited
Genx Diagnostics Limited
Prl Diagnostics Private Limited
Premium access

Shareholding and investment profile for Suryaprakasam Vedam Lakshmi Ramprasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suryaprakasam Vedam Lakshmi Ramprasad

Suryaprakasam Vedam Lakshmi Ramprasad currently holds 7 directorships: Medgenome Labs Limited (Ceo, since 16 Nov 2023, revenue ₹407 Cr (FY 2025)); Genx Diagnostics Limited (Director, since 21 Aug 2024, revenue ₹36.97 Cr (FY 2025)); Trident Diagnostics & Healthcare Private Limited (Director, since 20 May 2022, revenue ₹27.99 Cr (FY 2025)); Prl Diagnostics Private Limited (Director, since 10 Apr 2024, revenue ₹20.75 Cr (FY 2025)); Green Cross Genetics Lab Private Limited (Additional Director, since 18 Nov 2025, revenue ₹13.25 Cr (FY 2022)); and 2 more.

Suryaprakasam Vedam Lakshmi Ramprasad was first appointed on 20 May 2022 as Director at Trident Diagnostics & Healthcare Private Limited. The most recent appointment on record is 18 Nov 2025 at Green Cross Genetics Lab Private Limited.

The 7 current companies of Suryaprakasam Vedam Lakshmi Ramprasad that report revenue have a combined latest revenue of ₹509 Cr: Medgenome Labs Limited ₹407 Cr (FY 2025); Genx Diagnostics Limited ₹36.97 Cr (FY 2025); Trident Diagnostics & Healthcare Private Limited ₹27.99 Cr (FY 2025); Prl Diagnostics Private Limited ₹20.75 Cr (FY 2025); Green Cross Genetics Lab Private Limited ₹13.25 Cr (FY 2022); and 2 more.

The current boards of Suryaprakasam Vedam Lakshmi Ramprasad's companies include Mahesh Pratapneni (Medgenome Labs Limited), Navjeewan Jatinder Khosla (Medgenome Labs Limited), Prasad Bhagwan Shejale (Medgenome Labs Limited), Shankar Mahadevappa Prasad (Medgenome Labs Limited), Surajit Chakrabartty (Medgenome Labs Limited), Surajit Chakrabartty (Medgenome Labs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available